Zoetis Inc. (BMV:ZTS)

Market Cap	1.31T
Revenue (ttm)	189.80B
Net Income (ttm)	51.47B
Shares Out	n/a
EPS (ttm)	113.85
PE Ratio	25.48
Forward PE	24.54
Dividend	36.51 (1.22%)
Ex-Dividend Date	Apr 21, 2025

Volume	56
Average Volume	30
Open	2,995.80
Previous Close	3,090.00
Day's Range	2,995.80 - 2,995.80
52-Week Range	2,958.00 - 3,858.69
Beta	n/a
RSI	30.58
Earnings Date	Aug 5, 2025

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph...

• Industry: Pharmaceutical Preparations
• Founded: 1950
• Employees: 13,800
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: ZTS

Financial Performance

In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.

Financial numbers in USD